Tue, Feb 13, 2024
The Street estimates Ipca Labs' EBITDA to soar by 60 per cent to Rs 345 crore in the quarter under review from Rs 216 crore in the same quarter last fiscal. The pharma firm's margins, meanwhile, are estimated to rise to 16 per cent in the December quarter from 14 per cent in the third quarter last year.
More >
Mon, Oct 23, 2023
IPCA Laboratories' share price surged 7% to hit a 52-week high on Oct 23 after the company received a voluntary action indicated (VAI) classification for its Ratlam plant from the US FDA. What's a VAI classification and why is it good news for IPCA Laboratories?
Ipca Labs' shares had also hit a 52-week high on October 16, 17 and 18.
Mon, Jun 26, 2023
IPCA Labs: Share fell for the third consecutive day, Know about the full details
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
